Stock Quote

AstraZeneca PLC (AZN.L) (London Stock Exchange)
As of  11:35am EST
2,710.50GBp
Price Change
-21.50
Percent Change
-0.79%
 
2,710.50p
11:35am EST
-0.79%
2,732.00p
2,716.00p
2,834,469
2,750.00p
2,706.00p
2,966.00p
2,126.00p
0.43
2,864,482

Research Another Stock: Symbol Look-up
This Baby Is a Nice Addition
Friday, 20 Nov 2009 11:17am EST(The Motley Fool) 
BioMed News Bytes: AstraZeneca, Delcath, Unilife
Friday, 20 Nov 2009 08:24am EST(Seeking Alpha) 
Big Pharma Under Pressure as Drug Patents Expire and Pipeline Slows
Thursday, 19 Nov 2009 03:03pm EST(Seeking Alpha) 
Your Heart or Your Stomach?
Wednesday, 18 Nov 2009 10:32am EST(The Motley Fool) 
Drug Lowers Cholesterol; Stock Follows
Wednesday, 18 Nov 2009 10:24am EST(The Motley Fool) 
 
Name Current Position Compensation
Schweitzer, Louis Non-Executive Chairman of the Board 567,000
Brennan, David Chief Executive Officer, Executive Director 4,692,000
Lowth, Simon Chief Financial Officer, Executive Director 2,442,000

Profile

AstraZeneca PLC is a United Kingdom-based pharmaceutical company, which discovers, develops, manufactures and markets prescription pharmaceuticals, biologics and vaccines for areas of healthcare, such as cardiovascular, gastrointestinal, infection, neuroscience, oncology, respiratory and... Full Description

Company Address

AstraZeneca PLC
15 Stanhope Gate
London   ENG   W1K 1LN
P: +4420.73045000
F: +4420.73045151

Analyst Research

  AZN.L Industry
P/E(TTM) 9.12 3.60
P/S(TTM) 2.05 0.57
ROI(TTM) 20.62 1.86
ROE(TTM) 40.65 2.52
Consensus Recommendation Hold
EPS Est. (Current Period) --
EPS Est. (Current Year) --
Total Revenue $4,934.84M
Net Income $1,276.44M
EPS $0.88